Literature DB >> 20868558

Identification of differentially expressed genes related to radioresistance of human esophageal cancer cells.

Hong-Zhen Li1, Xian-Shu Gao, Wei Xiong, Jing Zhao, Hai Zhang, De-Min Zhou.   

Abstract

BACKGROUND AND
OBJECTIVE: Radioresistant cells in esophageal cancer is one of the important reasons for the local failure of radiotherapy. In recent years, some researchers used gene chip technology to screen the differentially expressed genes between parental and radioresistant human esophageal cancer cells. But there were some problems in these studies, for example comparing cells at only one time interval, and genetic background not matching. In this study, we selected 3 different pairs of parental and radioresistant human esophageal cancer cells, and compared the gene expression profiles by cDNA microarray at 3 time intervals to identify and analyze the differentially expressed genes between parental and radioresistant human esophageal cancer cells.
METHODS: We compared the gene expression profiles between parental cells (TE13, Seg-1, Kyse170) and radioresistant cells (TE13R, Seg-1R, Kyse170R) before, and at 8 h and 24 h after irradiation with a cDNA microarray consisting of 48 000 genes (Human Genome). We identified differentially expressed genes by Pathway and GO analyses, and verified the differentially expressed genes LEF1 and CTNNB1 by RT-PCR.
RESULTS: A total of 460, 451, and 397 differentially expressed genes were found before, and at 8 h and 24 h after irradiation. After Pathway and GO analyses, 14 differentially expressed genes, participating in cell growth, apoptosis, cell cycle regulation, gene repair and signal transmission, were selected to further research. LEF1 and CTNNB1 were verified by RT-PCR, and the results were consistent with those of cDNA microarray.
CONCLUSIONS: The WNT signal pathway may be an important pathway participating in the formation of radioresistance of esophageal cancer cells. LEF1 and CTNNB1 may be the important genes causing the esophageal cancer cell radioresistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868558     DOI: 10.5732/cjc.010.10148

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  6 in total

1.  MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Suna Zhou; Wenguang Ye; Juan Ren; Qiuju Shao; Yuhong Qi; Jun Liang; Mingxin Zhang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

2.  Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.

Authors:  Huandi Zhou; Ge Zhang; Xiaoying Xue; Yanling Yang; Ye Yang; Xiaojing Chang; Xiaohui Ge; Zhiqing Xiao; Han Guo; Yanqiang Wang
Journal:  Tumour Biol       Date:  2016-01-07

3.  NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Huandi Zhou; Guohui Wang; Zhiqing Xiao; Yu Yang; Zhesen Tian; Chen Gao; Xuetao Han; Wei Sun; Liubing Hou; Junling Liu; Xiaoying Xue
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

4.  Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stress.

Authors:  Wei Xiong; Jing Zhao; Hongliang Yu; Xiaoying Li; Shaoqian Sun; Yi Li; Qing Xia; Chuanling Zhang; Qiuchen He; Xianshu Gao; Lihe Zhang; Demin Zhou
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

5.  LIG4 mediates Wnt signalling-induced radioresistance.

Authors:  Sohee Jun; Youn-Sang Jung; Han Na Suh; Wenqi Wang; Moon Jong Kim; Young Sun Oh; Esther M Lien; Xi Shen; Yoshihisa Matsumoto; Pierre D McCrea; Lei Li; Junjie Chen; Jae-Il Park
Journal:  Nat Commun       Date:  2016-03-24       Impact factor: 14.919

6.  Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Ying-Ying Jin; Qing-Juan Chen; Yang Wei; Ya-Li Wang; Zhong-Wei Wang; Kun Xu; Yun He; Hong-Bing Ma
Journal:  J Radiat Res       Date:  2016-07-15       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.